MAYNE PHARMA GROUP LIMITED (MYX)
The development and manufacture of proprietary and generic productsOn this page you will find:
|
Delayed share price Company announcements Price history chart Exchange Traded Options |
|
Company details Closing prices Dividends Warrants & Structured Products ASX CFDs |
Delayed share price
Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.
| Code | Last | % Chg | Bid | Offer | Open | High | Low | Vol |
|---|---|---|---|---|---|---|---|---|
| MYX | 0.445 | -2.2% | 0.435 | 0.445 | 0.455 | 0.455 | 0.435 | 1,127,419 |
ASX Find a broker tool
Helps you find an ASX broker based on your needs and where you live.
MAYNE PHARMA GROUP LIMITED details
Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.
| Issuer Code | MYX |
|---|---|
| Securities | |
| Official Listing Date | 29 June, 2007 |
| GICS Industry Group | Pharmaceuticals, Biotechnology & Life Sciences |
| Exempt Foreign? | No |
| Internet Address | http://www.maynepharma.com |
| Registered Office Address | Level 14, 474 Flinders Street, MELBOURNE, VIC, AUSTRALIA, 3000 |
| Head Office Telephone | (03) 8614 7777 |
| Head Office Fax | (03) 9614 7022 |
| Share Registry | COMPUTERSHARE INVESTOR SERVICES PTY LIMITED YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067 |
| Share Registry Telephone | 1300 787 272 |
| Directors / Senior Management |
|---|
|
Mr Roger Corbett, AO (Chairman) Mr Scott Richards (CEO) Mr Phil Hodges (Executive Director) The Hon Ron Best (Non Exec. Director) Mr Bruce Mathieson (Non Exec. Director) Mr Ian Scholes (Non Exec. Director) Mr Mark Cansdale (CFO) Ms Lisa Pendlebury (Investor Relations) |
| Company Secretary |
Mr Mark Cansdale |
|---|---|
| Principal Activities | The development and manufacture of proprietary and generic products |
MAYNE PHARMA GROUP LIMITED announcements
How are company announcements published on www.asx.com.au?
| Date | Price sens. |
Headline | Pages | |
|---|---|---|---|---|
| 17/04/2013 | Ceasing to be a substantial holder | 2 | ||
| 12/04/2013 |
|
FDA Approval of New 200mg Doryx Tablet | 1 | |
| 10/04/2013 | UBS Emerging Companies Conference Presentation | 13 | ||
| 26/03/2013 | Ceasing to be a substantial holder | 3 | ||
| 25/03/2013 | Becoming a substantial holder | 5 | ||
| 21/03/2013 | Ceasing to be a substantial holder | 2 | ||
| 18/03/2013 | Change of Director's Interest Notice | 2 | ||
| 15/03/2013 | Change in substantial holding | 3 | ||
| 01/03/2013 |
|
S&P DJ Indices Announces March Quarterly Rebalance | 8 | |
| 27/02/2013 |
|
2013 Half Year Media Release | 6 |
> search for past company announcements
Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.
Closing prices
Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.
| Date | Last | % Change | High | Low | Vol * |
|---|---|---|---|---|---|
| 24 May 2013 | 0.445 | -2.2% | 0.455 | 0.435 | 1,127,419 |
| 23 May 2013 | 0.455 | 0% | 0.465 | 0.450 | 828,693 |
| 22 May 2013 | 0.455 | 0% | 0.455 | 0.450 | 478,467 |
| 21 May 2013 | 0.455 | 2.25% | 0.455 | 0.445 | 565,490 |
| 20 May 2013 | 0.445 | -1.11% | 0.465 | 0.445 | 548,673 |
* Volume of shares shown represents only those shares traded on ASX.
MAYNE PHARMA GROUP LIMITED price history chart

Dividends
How are dividends released on www.asx.com.au?
No dividends have been found for the security MYX. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.
Exchange Traded Options
No Exchange Traded Options are available over the security MYX
Warrants & Structured Products
No warrants & Structured Products are available over the security MYX
ASX CFDs
No Contracts For Differences are available over the security MYX

